Learn strategies to manage presbyopes from early to late stages of progression using new and emerging pharmaceutical treatments options as well as next-generation, presbyopia-correcting IOLs.
This activity is supported by unrestricted educational grants from AbbVie, Alcon, and Johnson & Johnson Vision.
Upon completion of this activity, the participant should be able to:
Sponsored by: 
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 124342, is accredited by COPE for continuing education for optometrists for 1 hour of CE.
Course #: 79233-TD
Activity #: 124342
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Marc R. Bloomenstein, OD, FAAO
Schwartz Laser Eye Center
Director of Optometric Services
Scottsdale, AZ
Josh K. Johnston, OD, FAAO
Residency Director and Clinical Director
Georgia Eye Partners
Atlanta, GA
Cecelia C. Koetting, OD, FAAO, Dipl ABO
Hines Sight
Denver, CO
Selina R. McGee, OD, FAAO, Dipl ABO
Intrepid Eye Society Vice-President
Oklahoma Association of Optometric Physicians-Past President
Founder/CEO, BeSpoke Vision
Edmond, OK
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Marc R. Bloomenstein, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Aerie Pharmaceuticals, Allergan, Azura, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OcuSoft, Sight Sciences, Sun Pharmaceutical Industries, and Tarsus. Grant/Research Support: Sight Sciences. Speaker’s Bureau: Allergan, Bausch + Lomb, Johnson & Johnson Vision, Kala Pharmaceuticals, OysterPoint, RVL, Sight Sciences, and Sun Pharmaceutical Industries.
Josh K. Johnston, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Astareal, Avellino, BioTissue, Bruder, Carl Zeiss Meditec, Dompé, Glaukos, Horizon Therapeutics, Johnson & Johnson Vision, Kala Pharmaceuticals, Maxi Vision, Orasis, Oyster Point Pharma, Quidel, SeaGen, Sight Sciences, Sun Pharmaceutical Industries, Tarsus, and Visus. Grant/Research Support: Allergan and Tarsus. Speaker’s Bureau: Allergan, BioTissue, Glaukos, Kala Pharmaceuticals, Oyster Point Pharma, Quidel, Sight Sciences, and Sun Pharmaceutical Industries.
Cecelia C. Koetting, OD, FAAO, Dipl ABO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Alcon, Aldeyra, Allergan, Avellino, Bruder, Dompé, Eyevance, Glaukos, Kala Pharmaceuticals, Orasis, OysterPoint, RVL, and Thea. Grant/Research Support: Johnson & Johnson Vision. Speaker's Bureau: Alcon, Dompé, Eyevance, OysterPoint, and RVL.
Selina R. McGee, OD, FAAO, Dipl ABO, has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan, Bruder, Cynosure, Dompé, Horizon Therapeutics, Kala Pharmaceuticals, Lumenis, Novartis, Optovue, Osmotica Pharmaceuticals, Science Based Health, Sun Pharmaceuticals, Tarsus, Thea, and Versant. Speaker's Bureau: Allergan, Dompé, Lumenis, and Optovue.
The Evolve and The Fundingsland Group staff, planners, and reviewers have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Abbvie, Alcon, or Johnson & Johnson Vision.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
The Missed Diagnosis: A 45-Year-Old Software Engineer Who Complains of Dry Eyes
1.00 program creditDouglas K. Devries, OD
Cecelia Koetting, OD, FAAO
Douglas K. Devries, OD
Cecelia Koetting, OD, FAAO
